Vectura
Veröffentlicht am: 27.12.2011 um 16:25 Uhr | Redaktionelle Verantwortung: Rafael Müller, Chefredakteur AD HOC NEWS
Vectura has eight marketed products and a portfolio of drugs in clinical and pre-clinical development, some of which have been licensed to major pharmaceutical companies. The Companyalsoprogresses certain programmes to a more advanced stage tooptimise their commercial value. In addition, Vecturaoffers its formulation and inhalation capabilities to other pharmaceutical companies on a licensing basis where thiscomplements Vectura’s business strategy.
Vectura was formed in 1997 with venture finance backing. Its aim wasto develop and commercialise opportunities based on the technologies that were emerging in the fast- growing drug delivery field.
Vectura is based in the UK, with headquarters and development operations in Chippenham, Wiltshire,further laboratories in Nottingham, and device development in Cambridge.
In 2007, Vectura acquired Innovata plc, a UK listed company that was developing pulmonary products using specialised device and formulation technologies and with a portfolio of marketed, revenue-generating products.
In July 2007 Vectura moved from AIM to the Official List on the London Stock Exchange. Its shares trade on the London Stock Exchange under the symbol VEC.
Vectura was formed in 1997 with venture finance backing. Its aim wasto develop and commercialise opportunities based on the technologies that were emerging in the fast- growing drug delivery field.
Vectura is based in the UK, with headquarters and development operations in Chippenham, Wiltshire,further laboratories in Nottingham, and device development in Cambridge.
In 2007, Vectura acquired Innovata plc, a UK listed company that was developing pulmonary products using specialised device and formulation technologies and with a portfolio of marketed, revenue-generating products.
In July 2007 Vectura moved from AIM to the Official List on the London Stock Exchange. Its shares trade on the London Stock Exchange under the symbol VEC.
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf- oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
de | GB00B01D1K48 | VECTURA | boerse | 22690461 |
